#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infective uveitis Fibrous dysplasia of bone Familial haemophagocytic lymphohistiocytosis Fatty acid oxidation disorder Thrombocytopenia Erdheim-Chester disease Pancreatic neuroendocrine tumour Monogenic diabetes Lennox-Gastaut syndrome Extra-osseous Ewing's sarcoma Haemophilia B with anti factor IX Short-bowel syndrome Cerebellar ataxia Porphyria non-acute Huntington's disease More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Life with Disease Erdheim-Chester disease – Treatment Hereditary optic atrophy – Basic Information Haemophilia B with anti factor IX – Diagnostics Isodicentric chromosome 15 syndrome – Basic Information Glycogen storage disease type I – Treatment Mucopolysaccharidosis – Life with Disease Optic glioma – Life with Disease Nephroblastoma – Life with Disease Hereditary motor and sensory neuropathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nazartinib Icatibant Masitinib AAV9-CTNT-COBAG3 Tarlatamab Niflumic Acid Ganirelix Mecillinam Estriol Fezolinetant Phleum Pratense (225) Cetrimide [14C] DC-806 Masupirdine Fipaxalparant Fingolimod Hydrochloride Ab-729 SKB410 Lebrikizumab ADX-038 More therapies…

    Learn about Your Condition

    Craniocerebral injury Colitis ulcerative Fontan procedure Heart disease congenital Depression Post-acute COVID-19 syndrome Cervical dysplasia HER2 negative breast cancer Infertility male Nephroblastoma Chorea Polycystic liver disease Glomerulonephritis acute Lymphocytic lymphoma Vertebrobasilar stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Doxycycline
    Belgium

  • A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Docetaxel
    • Enzalutamide
    France Germany Italy Spain

  • A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Aflibercept
    Bulgaria Czechia Hungary Latvia Poland Slovakia

  • A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral artery angioplasty
    • Peripheral artery thrombosis
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Clopidogrel
    France

  • Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    • Chronic kidney disease
    Investigated Drugs:
    • Levothyroxine
    Denmark

  • Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Glimepiride
    Denmark
Previous Page
1 … 47 48 49 50 51 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!